Approval · Notice of Compliance 26311 · 2021
BRUKINSA: Notice of Compliance 26311
Issued July 22, 2021
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 26311
- Date
- July 22, 2021
- Company
- Beigene Switzerland Gmbh
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Other
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| BRUKINSA | Not yet assigned | — |
Medicinal ingredients
- ZANUBRUTINIB 80 MG per CAP